Superworth

Precision Biosciences profit margin DTIL

Gross, operating and net profit as a share of revenue over the last twelve months, from 2021.

Net margin, 12 months
n/m
not a meaningful number
Operating margin, 12 months
−80.8%
Peer median
7.3%

Precision Biosciences' net margin works out at −117% over the last twelve months, but it is not a meaningful number: a margin outside minus 100% to 100% is moved by items that are not sales.

Profit margin over time

OperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating margin
FY2025n/an/a
FY202410.4%−38.1%
FY2023n/a−89.8%
FY2022n/an/a
FY2021−26.5%−34.1%
FY2020n/an/a
FY2019n/an/a
FY2018n/an/a

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY26n/an/a−80.8%
Q1 FY26−96.7%−53.7 pts−86.8%
Q4 FY25n/an/an/a
Q3 FY25n/an/an/a
Q2 FY25n/an/an/a
Q1 FY25−43.0%+5.1 pts−86.2%
Q4 FY2410.4%n/a−38.1%
Q3 FY2411.5%n/a−21.6%
Q2 FY2419.4%n/a−8.3%
Q1 FY24−48.1%n/a−60.1%
Q4 FY23n/an/a−89.8%
Q3 FY23n/an/a−94.4%

Against its peers

Companies in Healthcare nearest Precision Biosciences' size, closest first, today.

CompanyProfit margin
DTILPrecision Biosciencesn/m
PDEXPro DEX17.6%
PLXProtalix BioTherapeutics23.5%
NATRNatures Sunshine Products3.7%
ELMDElectromed15.3%
UTMDUtah Medical Products29.0%
INFUInfuSystem6.0%
KEQUKewaunee Scientific3.0%
ICCCImmucell2.6%
VMDViemed Healthcare4.8%
EMBCEmbecta8.6%
Peer median7.3%

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Precision Biosciences

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.